GOZETOTIDE
GOZETOTIDE is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Gozellix. Available dosage form: kit.
Drug Details
- Generic Name
- GOZETOTIDE
- Brand Names
- Gozellix
- Application Number
- NDA219592
- Sponsor
- Telix Innovations SA
- NDC Codes
- 1
- Dosage Forms
- KIT
- Routes
- N/A
- Active Ingredients
- N/A
Indications and Usage
1 INDICATIONS AND USAGE Gallium Ga 68 gozeotide injection is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. Gallium Ga 68 gozetotide injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. ( 1 )